Ajay Bansal

Ajay Bansal

Director of Finance/CFO at UROVANT SCIENCES LTD.
64 year
Health Technology
Commercial Services
Finance

Profile

Ajay Bansal currently works at Urovant Sciences Ltd., as Chief Financial Officer & SVP-Business Development from 2019.
Mr. Bansal also formerly worked at Capital One Financial Corp., as Director-Operations Analysis from 2002 to 2003, Nektar Therapeutics, as Chief Financial Officer from 2003 to 2006, Lexicon Pharmaceuticals, Inc., as CFO & Executive VP-Business Development in 2010, Tercica, Inc., as CFO & Executive VP-Business Development from 2007 to 2008, Onconova Therapeutics, Inc., as Chief Financial Officer & Secretary from 2014 to 2016, ViewRay Technologies, Inc., as Chief Financial & Accounting Officer, Complete Genomics, Inc., as Chief Financial Officer from 2012 to 2013, ViewRay, Inc., as Chief Financial & Accounting Officer from 2016 to 2019, McKinsey & Co., Inc., as Engagement Manager from 1988 to 1991, Mehta Partners LLC, as Partner from 1998 to 2002, ZS Associates, Inc., as Consultant from 1985 to 1987, and Novartis Pharmaceuticals Corp., as Principal.
Mr. Bansal received his graduate degree in 1985 and Masters Business Admin degree in 1985 from Northwestern University and undergraduate degree in 1984 from Indian Institute of Technology New Delhi.

Ajay Bansal active positions

CompaniesPositionStart
UROVANT SCIENCES LTD. Director of Finance/CFO 28/10/2019

Former positions of Ajay Bansal

CompaniesPositionEnd
VIEWRAY SYSTEMS, INC. Director of Finance/CFO 30/09/2019
TRAWS PHARMA, INC. Director of Finance/CFO 12/02/2016
COMPLETE GENOMICS, INC. Director of Finance/CFO 01/03/2013
LEXICON PHARMACEUTICALS, INC. Director of Finance/CFO 08/01/2010
Director of Finance/CFO 01/10/2008
See the detail of Ajay Bansal's experience

Training of Ajay Bansal

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

70

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Finance

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!